Rush MD Anderson Cancer Center — Chicago, Illinois

Rush MD Anderson Cancer Center is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Rush MD Anderson Cancer Center has participated in 92 clinical trials with 89 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7.

Sponsors: National Cancer Institute (NCI), NRG Oncology, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush MD Anderson Cancer Center?

Rush MD Anderson Cancer Center has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush MD Anderson Cancer Center conducted?

Rush MD Anderson Cancer Center has 92 clinical trials on record, with 89 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7.

Is Rush MD Anderson Cancer Center accredited by Crixeo Health?

Rush MD Anderson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rush MD Anderson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.